FilingReader Intelligence
United Laboratories receives FDA approval for obesity drug
July 10, 2025 at 04:39 AM UTC•By FilingReader AI
The United Laboratories International Holdings announced that it received FDA approval for its investigational new drug application (IND) for UBT37034 Injection on July 4, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
HKEX:3933•Hong Kong Exchange
News Alerts
Get instant email alerts when The United Laboratories International Holdings publishes news
Free account required • Unsubscribe anytime